Welcome to our dedicated page for MSP Recovery SEC filings (Ticker: MSPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The MSP Recovery, Inc. (MSPR) SEC filings page brings together the company’s official disclosures to the U.S. Securities and Exchange Commission, offering insight into its reimbursement recovery business, technology initiatives, capital structure, and listing status. MSP Recovery describes itself as a Medicare, Medicaid, commercial, and secondary payer reimbursement recovery and technology leader, and its filings expand on how this model operates in practice.
Through annual reports on Form 10‑K and quarterly reports on Form 10‑Q, MSP Recovery provides detailed information on its portfolio of assigned healthcare claims, legal strategies under the Medicare Secondary Payer Act and other laws, technology platforms such as LifeWallet and LifeChain, and risk factors related to liquidity, litigation, and regulatory matters. These periodic reports also discuss non‑GAAP measures, impairment assessments of definite‑lived intangible assets, and management’s views on going‑concern considerations.
Current reports on Form 8‑K document material events affecting the company. Recent 8‑Ks describe strategic term sheets with investors such as Hazel Partners and Virage Capital Management, bridge funding and working‑capital facilities, debt‑to‑equity conversions, and amendments to agreements with YA II PN, Ltd. (Yorkville) under a Standby Equity Purchase Agreement and related convertible promissory notes. Other 8‑Ks address reverse stock splits implemented to address Nasdaq’s minimum bid‑price rule, confidential settlements with insurers and pharmaceutical defendants, and the settlement of litigation with counterparties such as Cano Health.
Filings under Item 3.01 of Form 8‑K and related disclosures outline Nasdaq listing‑compliance issues, including deficiencies in minimum stockholders’ equity and bid‑price requirements, the company’s submission of a compliance plan, and the subsequent Nasdaq Hearings Panel decision to delist MSP Recovery’s common stock from the Nasdaq Capital Market. The company reports that it expects its common stock to trade on the OTC Markets OTCQB market under the ticker MSPR following suspension from Nasdaq, which is an important consideration for investors tracking trading venues.
Notifications of late filing on Form 12b‑25 (NT 10‑Q) provide context when MSP Recovery is unable to file a quarterly report by the prescribed deadline, such as delays related to a transition to a new independent registered public accounting firm. These notices explain the reasons for the delay and whether the company expects to file within the permitted extension period.
On this page, users can review MSP Recovery’s 10‑K and 10‑Q reports, 8‑K current reports, and other SEC submissions, while AI‑powered tools summarize key sections, highlight significant changes, and call out items such as liquidity discussions, debt and equity arrangements, reverse stock splits, and listing‑status disclosures. This helps readers quickly understand how MSP Recovery’s legal, technological, and financial developments are reflected in its official regulatory record.
MSP Recovery, Inc. reports that a Nasdaq Hearings Panel has denied its appeal of prior Nasdaq staff determinations, and the company’s Class A common stock will be delisted from the Nasdaq Capital Market for failing to meet continued listing standards. Nasdaq cited MSP Recovery’s stockholders’ equity being below the required $2.5 million minimum and the company’s failure to meet alternative standards tied to a $35 million market value of listed securities or $500,000 in net income from continuing operations. The company also fell out of compliance with Nasdaq’s $1.00-per-share minimum bid price rule. Trading on Nasdaq will be suspended at the open on December 22, 2025, and the company expects its common stock to continue trading on the OTC Markets OTCQB market under the ticker “MSPR.”
MSP Recovery, Inc. is updating a resale registration covering up to 909,982 shares of Class A common stock, related warrants, and up to 236,019 shares issuable upon warrant exercise. These securities may be sold from time to time by existing holders; the company itself would receive only nominal cash (less than
The attached quarterly report shows very limited liquidity and heavy losses. As of
The company discloses “substantial doubt” about its ability to continue as a going concern and notes dependence on the Yorkville standby equity facility and a fully drawn Hazel working capital facility. It warns that, without new funding, it may need to pursue insolvency or U.S. bankruptcy protection. Nasdaq has issued a delisting determination for failing the minimum equity requirement, and MSP Recovery is appealing at a hearing scheduled for
MSP Recovery, Inc. filed a prospectus supplement covering the resale of up to 32,220 shares of Class A common stock by existing holders, including 15,239 shares issuable upon exercise of the low-priced CPIA warrant at $0.4375 per share, from which the company would receive only nominal proceeds. The supplement incorporates the company’s Q3 2025 results.
For the quarter ended September 30, 2025, MSP Recovery generated $0.2 million in revenue and recorded a net loss of $245.5 million, contributing to a nine‑month net loss of $723.3 million. As of September 30, 2025, the company reported cash of about $1.8 million, total assets of $1.55 billion, total liabilities of $2.40 billion, and a stockholders’ deficit of $563.8 million, with total equity of $(844.4) million. Management states there is substantial doubt about its ability to continue as a going concern, given heavy dependence on Yorkville financing and constrained access to other funding.
The company executed a 1‑for‑7 reverse stock split effective September 1, 2025 and faces listing pressure. Nasdaq has issued a delisting determination for failure to meet the minimum equity requirement, and MSP Recovery has requested a hearing scheduled for December 11, 2025. If it cannot maintain its Nasdaq listing, it expects its shares to trade on the OTCQB market.
MSP Recovery, Inc. (MSPR)56,896 shares of Class A common stock held by existing investors, including shares issuable upon low-priced VRM and VRP warrants, from which the company would receive only nominal cash if exercised. The supplement attaches the latest quarterly report, which shows severe financial stress, including an operating loss of $375.5 million and a net loss of $723.3 million for the nine months ended September 30, 2025.
As of that date, MSP Recovery had $1.8 million of cash, a stockholders’ deficit of $563.8 million, and total liabilities of $2.4 billion, along with a large guaranty obligation tied to its Virage financing. Management discloses “substantial doubt” about the company’s ability to continue as a going concern, noting dependence on the Yorkville standby equity facility and fully drawn Hazel credit lines, and warning that failure to secure funding could lead to insolvency or bankruptcy proceedings. The company has also received a Nasdaq delisting determination over minimum equity requirements and plans to argue for continued listing, while shares may move to the OTCQB if delisted.
MSP Recovery, Inc. is registering up to 285,715 shares of Class A common stock for resale by Yorkville under a standby equity purchase agreement. The company may sell shares to Yorkville under this facility, but will not receive proceeds from Yorkville’s resales.
The Yorkville SEPA allows MSP Recovery to sell up to
Stockholders’ equity was a deficit of
MSP Recovery, Inc. reports extremely weak results and severe financial strain for the quarter ended September 30, 2025. Claims recovery income fell to just
At September 30, 2025, cash was only
The company effected a 1‑for‑7 reverse stock split on September 1, 2025 and, as of November 14, 2025, had 13,774,399 Class A and 474,740 Class V shares outstanding. Nasdaq has issued a delisting determination for failure to meet the minimum stockholders’ equity requirement; trading is being kept pending a December 11, 2025 hearing, with no assurance of a favorable outcome.
MSP Recovery, Inc. filed a Form 12b-25 to notify a delayed filing of its Form 10‑Q for the quarter ended September 30, 2025. The company cites a recent transition to Baker Tilly US, LLP as its independent auditor and ongoing activities with the predecessor firm as the principal reason for the delay.
The company checked that the 10‑Q will be filed on or before the fifth calendar day following the prescribed due date and stated it expects to file within the grace period under Rule 12b‑25. MSP Recovery indicated that all other required periodic reports over the past 12 months have been filed and that it does not anticipate any significant change in results of operations versus the corresponding prior-year period in the upcoming report.
MSP Recovery (MSPR) filed Prospectus Supplement No. 51 registering for resale up to 909,982 shares of Class A common stock, the resale of up to 755,200,000 warrants, and the potential issuance of up to 236,019 shares upon warrant exercise, after effectiveness and subject to terms described. The company expects only nominal proceeds from Public Warrant exercises and states it will not retain any proceeds from exercises of the New Warrants.
The supplement attaches a Current Report that updates financing and listing developments. The Floor Price under the Yorkville standby equity facility and related convertible notes was reduced to $0.50. Yorkville advanced a
MSP Recovery, Inc. filed Prospectus Supplement No. 44 for the resale of up to 32,220 shares of Class A Common Stock by selling securityholders, including up to 15,239 shares issuable upon exercise of the CPIA Warrant at an exercise price of $0.4375 per share. The company will not receive proceeds from sales by the selling holders; it would receive only nominal proceeds if the CPIA Warrant is exercised.
The supplement attaches a Current Report on Form 8-K. The company and Yorkville reduced the SEPA floor price from $1.00 to $0.50 and Yorkville advanced a $0.50 million convertible note on October 28, 2025, resulting in net proceeds of $0.45 million. Convertible notes may convert at the lower of a fixed price or 95% of the lowest daily VWAP over five days, not below the $0.50 floor, subject to a 9.99% ownership cap. The Nomura note was amended to reflect approximately $35.4 million principal and to allow up to $3.0 million of SEPA proceeds to fund operations. Nasdaq issued a delisting determination on October 22, 2025; the company intends to request a panel review.
MSP Recovery (MSPR) filed Prospectus Supplement No. 33 covering the resale of up to 56,896 shares of Class A common stock by selling securityholders. The shares include up to 28,572 issuable upon exercise of VRM warrants, 2,858 issued to VRP and up to 14,286 issuable upon exercise of a VRP warrant, and 11,180 issued to Palantir. With a warrant exercise price of $0.0175 per share, the company would receive only nominal proceeds upon any warrant exercises; it would not receive proceeds from selling stockholder resales.
The attached update discloses a reduction of the Yorkville SEPA Floor Price from $1.00 to $0.50, and an additional Convertible Promissory Note advance of $0.50 million, yielding $0.45 million in net proceeds, with conversion at the lower of the fixed price or 95% of the 5‑day low VWAP, but not below $0.50, subject to a 9.99% ownership cap. The Nomura note was amended to reflect about $35.4 million principal and a limited waiver allowing up to $3.0 million of Yorkville convertible proceeds to fund operations. Nasdaq issued a delisting determination with trading suspension set for October 31, 2025, which the company plans to appeal. A 1‑for‑7 reverse split was effective September 1, 2025.